相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Vascular endothelial S1pr1 ameliorates adverse cardiac remodelling via stimulating reparative macrophage proliferation after myocardial infarction
Yashu Kuang et al.
CARDIOVASCULAR RESEARCH (2021)
Network Analysis Reveals a Distinct Axis of Macrophage Activation in Response to Conflicting Inflammatory Cues
Xiaji Liu et al.
JOURNAL OF IMMUNOLOGY (2021)
Reperfused vs. nonreperfused myocardial infarction: when to use which model
Merry L. Lindsey et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2021)
Lipoxygenase inhibitor ML351 dysregulated an innate inflammatory response leading to impaired cardiac repair in acute heart failure
Bochra Tourki et al.
BIOMEDICINE & PHARMACOTHERAPY (2021)
Heart Disease and Stroke Statistics-2020 Update: A Report From the American Heart Association
Salim S. Virani et al.
CIRCULATION (2020)
Race-based and sex-based differences in bioactive lipid mediators after myocardial infarction
Ganesh V. Halade et al.
ESC HEART FAILURE (2020)
Depletion of adipocyte sphingosine kinase 1 leads to cell hypertrophy, impaired lipolysis, and nonalcoholic fatty liver disease
Andrea K. Anderson et al.
JOURNAL OF LIPID RESEARCH (2020)
Identification of lysophosphatidylcholines and Sphingolipids as Potential Biomarkers for Acute Aortic Dissection via Serum Metabolomics
Xiushi Zhou et al.
EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY (2019)
Potential therapeutic targets for atherosclerosis in sphingolipid metabolism
Zemou Yu et al.
CLINICAL SCIENCE (2019)
Race, Natriuretic Peptides, and High-Carbohydrate Challenge A Clinical Trial
Nirav Patel et al.
CIRCULATION RESEARCH (2019)
Sphingosine 1-phosphate: Lipid signaling in pathology and therapy
Andreane Cartier et al.
SCIENCE (2019)
The Spleen in Myocardial Infarction
Gerd Heusch
CIRCULATION RESEARCH (2019)
Exploring the Protective Role and the Mechanism of Sphingosine 1 Phosphate in Endotoxic Cardiomyocytes
Feng Kuai et al.
SHOCK (2019)
Guidelines for experimental models of myocardial ischemia and infarction
Merry L. Lindsey et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2018)
Heart functional and structural compendium of cardiosplenic and cardiorenal networks in acute and chronic heart failure pathology
Ganesh V. Halade et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2018)
Excess ω-6 fatty acids influx in aging drives metabolic dysregulation, electrocardiographic alterations, and low-grade chronic inflammation
Vasundhara Kain et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2018)
Facile determination of sphingolipids under alkali condition using metal-free column by LC-MS/MS
Siddabasave Gowda B. Gowda et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2018)
Sphingosine-1-phosphate receptors and innate immunity
Arielle M. Bryan et al.
CELLULAR MICROBIOLOGY (2018)
S1P-S1PR2 Axis Mediates Homing of Muse Cells Into Damaged Heart for Long-Lasting Tissue Repair and Functional Recovery After Acute Myocardial Infarction
Yoshihisa Yamada et al.
CIRCULATION RESEARCH (2018)
Splenic leukocytes define the resolution of inflammation in heart failure
Ganesh V. Halade et al.
SCIENCE SIGNALING (2018)
Splenic leukocytes define the resolution of inflammation in heart failure
Ganesh V. Halade et al.
SCIENCE SIGNALING (2018)
Post-Myocardial Infarction Heart Failure
M. Cecilia Bahit et al.
JACC-HEART FAILURE (2018)
Plasma sphingosine-1-phosphate concentrations are associated with systolic heart failure in patients with ischemic heart disease
Amin Polzin et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2017)
SPHINGOSINE-1 PHOSPHATE IS A NOVEL BIOMARKER THAT CORRELATES WITH STEM CELL MOBILIZATION AND CLINICAL OUTCOMES IN PATIENTS WITH ST-ELEVATION MYOCARDIAL INFARCTION
Mohammad Mathbout et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Lipid profile, cardiovascular disease and mortality in a Mediterranean high-risk population: The ESCARVAL-RISK study
Domingo Orozco-Beltran et al.
PLOS ONE (2017)
Cardiovascular Health in African Americans A Scientific Statement From the American Heart Association
Mercedes R. Carnethon et al.
CIRCULATION (2017)
Defining the sham environment for post-myocardial infarction studies in mice
Rugmani Padmanabhan Iyer et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2016)
Sphingosine 1-phosphate signaling contributes to cardiac inflammation, dysfunction, and remodeling following myocardial infarction
Fuyang Zhang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2016)
Decreased phosphatidylcholine plasmalogens - A putative novel lipid signature in patients with stable coronary artery disease and acute myocardial infarction
Iryna Sutter et al.
ATHEROSCLEROSIS (2016)
Knowledge gaps to understanding cardiac macrophage polarization following myocardial infarction
Merry L. Lindsey et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2016)
Sphingosine-1-Phosphate Receptor Agonist Fingolimod Increases Myocardial Salvage and Decreases Adverse Postinfarction Left Ventricular Remodeling in a Porcine Model of Ischemia/Reperfusion
Carlos G. Santos-Gallego et al.
CIRCULATION (2016)
Chronic Heart Failure and Inflammation What Do We Really Know?
Sarah A. Dick et al.
CIRCULATION RESEARCH (2016)
Sphingosine 1-phosphate receptor-1 in cardiomyocytes is required for normal cardiac development
Hilary Clay et al.
DEVELOPMENTAL BIOLOGY (2016)
Sphingolipid De Novo Biosynthesis: A Rheostat of Cardiovascular Homeostasis
Linda Sasset et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2016)
Sphingosine-1-Phosphate Receptor 1 Regulates Cardiac Function by Modulating Ca2+ Sensitivity and Na+/H+ Exchange and Mediates Protection by Ischemic Preconditioning
Petra Keul et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2016)
Sphingosine 1-phosphate signaling impacts lymphocyte migration, inflammation and infection
Irina V. Tiper et al.
PATHOGENS AND DISEASE (2016)
A map of the distribution of sphingosine 1-phosphate in the spleen
Willy D. Ramos-Perez et al.
NATURE IMMUNOLOGY (2015)
Pharmacological Elevation of Circulating Bioactive Phosphosphingolipids Enhances Myocardial Recovery After Acute Infarction
Yuri M. Klyachkin et al.
STEM CELLS TRANSLATIONAL MEDICINE (2015)
Inflammation revisited: inflammation versus resolution of inflammation following myocardial infarction
Vasundhara Kain et al.
BASIC RESEARCH IN CARDIOLOGY (2014)
An update on the biology of sphingosine 1-phosphate receptors
Victoria A. Blaho et al.
JOURNAL OF LIPID RESEARCH (2014)
β1-Adrenergic Receptor and Sphingosine-1-Phosphate Receptor 1 (S1PR1) Reciprocal Downregulation Influences Cardiac Hypertrophic Response and Progression to Heart Failure Protective Role of S1PR1 Cardiac Gene Therapy
Alessandro Cannavo et al.
CIRCULATION (2013)
Matrix Metalloproteinase-28 Deletion Exacerbates Cardiac Dysfunction and Rupture After Myocardial Infarction in Mice by Inhibiting M2 Macrophage Activation
Yonggang Ma et al.
CIRCULATION RESEARCH (2013)
Sustained decrease in plasma sphingosine-1-phosphate concentration and its accumulation in blood cells in acute Myocardial infarction
Malgorzata Knapp et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2013)
Serum sphingolipids level as a novel potential marker for early detection of human myocardial ischaemic injury
Emmanuel E. Egom et al.
FRONTIERS IN PHYSIOLOGY (2013)
Myocardial infarction differentially alters sphingolipid levels in plasma, erythrocytes and platelets of the rat
Malgorzata Knapp et al.
BASIC RESEARCH IN CARDIOLOGY (2012)
Sphingosine 1-Phosphate as a Therapeutic Target in Heart Failure More Questions Than Answers
Douglas L. Mann
CIRCULATION (2012)
Hypoxic preconditioning induces stroke tolerance in mice via a cascading HIF, sphingosine kinase, and CCL2 signaling pathway
Bradley K. Wacker et al.
JOURNAL OF NEUROCHEMISTRY (2012)
Sphingosine-1-Phosphate Receptor 3 Promotes Recruitment of Monocyte/Macrophages in Inflammation and Atherosclerosis
Petra Keul et al.
CIRCULATION RESEARCH (2011)
S1P, dihydro-S1P and C24:1-ceramide levels in the HDL-containing fraction of serum inversely correlate with occurrence of ischemic heart disease
Kelley M. Argraves et al.
LIPIDS IN HEALTH AND DISEASE (2011)
Sphingolipid signaling and treatment during remodeling of the uninfarcted ventricular wall after myocardial infarction
Che-Chung Yeh et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2009)
Sphingosine-1-phosphate receptor signalling in the heart
Christopher K. Means et al.
CARDIOVASCULAR RESEARCH (2009)
Erythrocytes store and release sphingosine 1-phosphate in blood
Petra Haenel et al.
FASEB JOURNAL (2007)
Lysophospholipid receptors: Signalling, pharmacology and regulation by lysophospholipid metabolism
Dagmar Meyer zu Heringdorf et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2007)
Lysophospholipids increase IL-8 and MCP-1 expressions in human umbilical cord vein endothelial cells through an IL-1-dependent mechanism
Chi Iou Lin et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2006)
High-density lipoproteins and their constituent, sphingosine-1-phosphate, directly protect the heart against ischemia/reperfusion injury in vivo via the S1P3 lysophospholipid receptor
Gregor Theilmeier et al.
CIRCULATION (2006)
G-protein-coupled receptor S1P1 acts within endothelial cells to regulate vascular maturation
ML Allende et al.
BLOOD (2003)
The sphingosine kinase 1/sphingosine-1-phosphate pathway mediates COX-2 induction and PGE2 production in response to TNF-α
BJ Pettus et al.
FASEB JOURNAL (2003)
分享论文
